Dexcom | DXCM - Pre Tax Profit

Stock Price
61.53
Daily Change
1.98 3.32%
Monthly
-1.11%
Yearly
-24.61%
Q2 Forecast
60.25

Dexcom reported $340.7M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Abbott USD 2.39B 27M Mar/2026
Align Technology USD 148.89M 27.71M Mar/2026
AtriCure USD 2.36M 2.45M Dec/2025
Avanos Medical USD -1.2M 74.7M Sep/2025
Baxter International USD -756M 877M Dec/2025
Becton, Dickinson and Co. USD 393M 117M Dec/2025
Boston Scientific USD 700M 238M Dec/2025
Cooper Companies USD 116.8M 137.4M Sep/2025
Dexcom USD 340.7M 40.7M Dec/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Globus Medical USD 143.99M 44.18M Sep/2025
Inogen USD -6.06M 467K Sep/2024
Insulet USD 140.2M 17.4M Dec/2025
Integra LifeSciences USD -6.82M 524.13M Sep/2025
J&J USD 7.82B 2.86B Mar/2026
Masimo USD 74.9M 19.5M Sep/2025
Medtronic USD 2.1B 224M Sep/2025
Merit Medical Systems USD 51.06M 22.12M Dec/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Solventum Corp USD 511M 149M Sep/2025
Stryker USD 1.7B 676M Dec/2025
Tandem Diabetes Care USD -25.14M 32.58M Sep/2025
Teleflex USD -438.58M 573.82M Sep/2025
West Pharmaceutical Services USD 161.5M 8.6M Dec/2025
Zimmer Biomet Holdings USD 98M 320.7M Dec/2025